Question

A 32-year-old with AF (CHA₂DS₂‑VASc 2) declines anticoagulation. What is the absolute risk reduction with DOACs vs no therapy?

Accepted Answer

Stroke risk reduction ~60-70% vs no therapy

Answer

Guidelines quantify ARR precisely at 50% for all

Answer

Risk reduction ~10%

Answer

No reduction vs no therapy

Answer

Only bleeding risk changes

Practice question

A 32-year-old with AF (CHA₂DS₂‑VASc 2) declines anticoagulation. What is the absolute risk reduction with DOACs vs no therapy?